Table 1.
Controls | Immune Cell Profiling | IO Drug Target | Immune Activation Status | Immune Cell Typing | Pan-Tumour Module |
---|---|---|---|---|---|
Rb IgG | PD-1 | 4-1BB | CD127 | CD45RO | MART1 |
Ms IgG1 | CD68 | LAG3 | CD25 | FOXP3 | NY-ESO-1 |
Ms IgG2a | HLA-DR | OX40L | CD80 | CD34 | S100B |
Histone H3 | Ki-67 | Tim-3 | ICOS | CD66b | Bcl-2 |
S6 | Beta-2M | VISTA | PD-L2 | FAP-alpha | EpCAM |
GAPDH | CD11c | ARG1 | CD40 | CD14 | Her2 |
CD20 | B7-H3 | CD44 | CD163 | PTEN | |
CD3 | IDO1 | CD27 | ER-alpha | ||
CD4 | STING | PR | |||
CD45 | GITR | ||||
CD56 | |||||
CD8 | |||||
CTLA4 | |||||
GZMB | |||||
PD-L1 | |||||
PanCk | |||||
SMA | |||||
Fibronectin |